Psychiatry & Neurology Doctors in Lake Elmo, MN Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Kent Gregory Brockmann, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 8673 Eagle Point Blvd, Lake Elmo, MN 55042 Phone: 651-209-9383    Fax: 651-209-9384

Amee Natvar Chandrabalan, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 8515 Eagle Point Blvd Ste 100, Lake Elmo, MN 55042 Phone: 612-879-1000    Fax: 612-879-9116

Katlyn Arndt, PA-C Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 8515 Eagle Point Blvd, Lake Elmo, MN 55042 Phone: 612-879-1000

Taylor Ann Paulson, PA Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 8515 Eagle Point Blvd Ste 100, Lake Elmo, MN 55042 Phone: 612-879-1000    Fax: 612-879-9116

Justin Quilop Garcia, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 8550 Hudson Blvd N, Lake Elmo, MN 55042 Phone: 651-254-8580

Laura Bergstrom, PA Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 8515 Eagle Point Blvd, Lake Elmo, MN 55042 Phone: 612-879-1000

News Archive

Democrats to unveil options to pay for 'doc fix,' other measures

Republicans expect to receive on Thursday a list of Democratic options to pay for a large tax-cut extension measure that includes a freeze in scheduled cuts to Medicare physician pay rates. However, at least one Republican expects negotiations on the legislation to make little progress before a law freezing current policy in place expires at the end of the month.

Certain soil types serve as natural prion repositories in the wild

Scientists have confirmed that prions, the mysterious proteins thought to cause chronic wasting disease (CWD) in deer, latch on tightly to certain minerals in soil and remain infectious.

Femta Pharmaceuticals, Lonza Group collaborate in cGMP production of FM101 antibody

Femta Pharmaceuticals and Lonza Group Ltd jointly announce the execution of a manufacturing services agreement to facilitate the development and cGMP manufacturing of FM101. FM101 is a high affinity monoclonal antibody in late pre-clinical development for the treatment of Rheumatoid Arthritis.

Study provides greater detail about the characteristics of COVID-19 patients

Patients hospitalized with COVID-19 were more likely male, younger, and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published by the Observational Health Data Sciences and Informatics community.

LACV-infected cerebral organoids reveal how to protect neurons from virus-induced death

Scientists have determined that La Crosse virus, which can cause inflammation of the brain, or encephalitis, in children, affects brain cells differently depending on their developmental stage.

Read more Medical News

› Verified 6 days ago